MY185184A - Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains - Google Patents

Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains

Info

Publication number
MY185184A
MY185184A MYPI2015001671A MYPI2015001671A MY185184A MY 185184 A MY185184 A MY 185184A MY PI2015001671 A MYPI2015001671 A MY PI2015001671A MY PI2015001671 A MYPI2015001671 A MY PI2015001671A MY 185184 A MY185184 A MY 185184A
Authority
MY
Malaysia
Prior art keywords
cold
temperature sensitive
strains
adapted temperature
enterovirus
Prior art date
Application number
MYPI2015001671A
Other languages
English (en)
Inventor
Kaw Bing Chua
Original Assignee
Temasek Life Sciences Laboratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temasek Life Sciences Laboratory Ltd filed Critical Temasek Life Sciences Laboratory Ltd
Publication of MY185184A publication Critical patent/MY185184A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32311Enterovirus
    • C12N2770/32321Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32311Enterovirus
    • C12N2770/32334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MYPI2015001671A 2013-01-18 2013-01-18 Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains MY185184A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2013/000027 WO2014112945A1 (en) 2013-01-18 2013-01-18 Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains

Publications (1)

Publication Number Publication Date
MY185184A true MY185184A (en) 2021-04-30

Family

ID=51209913

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015001671A MY185184A (en) 2013-01-18 2013-01-18 Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains

Country Status (7)

Country Link
JP (1) JP6117379B2 (ja)
CN (1) CN104918636B (ja)
HK (1) HK1213474A1 (ja)
MY (1) MY185184A (ja)
SG (1) SG11201505468VA (ja)
TW (1) TWI705140B (ja)
WO (1) WO2014112945A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106795499B (zh) * 2014-06-12 2021-05-14 淡马锡生命科学研究院有限公司 稳定的冷适应的温度敏感性嵌合肠道病毒的开发
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
MA41506A (fr) * 2015-02-13 2017-12-19 Takeda Vaccines Inc Procédés de production de virus pour produire des vaccins
CN109504662B (zh) * 2018-11-09 2022-06-10 浙江天元生物药业有限公司 一种柯萨奇病毒减毒株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150984B2 (en) * 1994-07-11 2006-12-19 The United States Of America As Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
KR20020013466A (ko) * 1998-09-01 2002-02-20 로버트 오 웹스터 온도-민감 및 한랭-적응 인간 파라인플루엔자 바이러스 제2 형 (hpiv-2) 및 상기 바이러스 기재의 백신

Also Published As

Publication number Publication date
CN104918636A (zh) 2015-09-16
HK1213474A1 (zh) 2016-07-08
TW201522642A (zh) 2015-06-16
CN104918636B (zh) 2018-06-26
TWI705140B (zh) 2020-09-21
WO2014112945A1 (en) 2014-07-24
JP2016511634A (ja) 2016-04-21
JP6117379B2 (ja) 2017-04-19
SG11201505468VA (en) 2015-08-28

Similar Documents

Publication Publication Date Title
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
MX2020009461A (es) Anticuerpos anti-proteína que contiene dominio de inmunologlubina rfig elacionado con el receptor de poliovirus (pvrig) y métodos de uso.
MX2018012880A (es) Metodos para proporcionar arn de hebra sencilla.
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
CL2016002455A1 (es) Anticuerpos multiespecíficos.
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
MX2018010295A (es) Anticuerpos que tienen especificidad para atenuador de linfocitos b y t (btla) y usos de los mismos.
MX2015017331A (es) Anticuerpos anti fc similar a receptor 5 (fcrh5).
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
MX2016003129A (es) Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano.
NZ761537A (en) Anti-human ox40l antibodies, uses & methods
TR201900124T4 (tr) Dispersiyon Reçineleri
PH12016501968A1 (en) Novel macrocyclic compounds
MX2021004464A (es) Compuestos de tiazolida para el tratamiento de infecciones virales.
MY185184A (en) Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains
HK1211622A1 (en) Mutant vaccinia virus strains, uses thereof and method of producing the same
MX2016002027A (es) Nuevos anticuerpos anti receptores iib fc-gama y usos de los mismos.
MX2015015798A (es) Elemento de filtro, metodo de fabricacion y uso del mismo.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2016007884A (es) Biomarcadores para la respuesta al tratamiento del hbv.
IN2013CH05383A (ja)
MX2022010854A (es) Peptidos toxicos activados artificialmente.
MA38701A1 (fr) Fond de poche et poche
IN2013CH05865A (ja)
ITVT20140004U1 (it) Ancora che grazie all'oscillazione di fuso e marra si recupera sempre facilmente.